|
|
|
|
LEADER |
01986nmm a2200457 u 4500 |
001 |
EB001876051 |
003 |
EBX01000000000000001039418 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
191110 ||| eng |
100 |
1 |
|
|a Bazan, Nicolas G.
|
245 |
0 |
0 |
|a Photoreceptor protection
|h Elektronische Ressource
|b significance of docosanoids and elovanoids. Part 1 of 2, docosahexaenoic acid (DHA)
|c Nicolas Bazan
|
246 |
3 |
1 |
|a significance of docosanoids and elovanoids. Part 1, Docosahexaenoic acid (DHA)
|
246 |
3 |
1 |
|a Docosahexaenoic acid (DHA)
|
260 |
|
|
|a London
|b Henry Stewart Talks
|c 2019, 2019
|
300 |
|
|
|a 1 streaming video file (33 min.)
|b color, sound
|
505 |
0 |
|
|a Biosynthesis of docosanoids -- Essential fatty acids -- Neuroprotective bioactivity during oxidative stress -- AdipoR1 as a regulatory switch of the DHA.
|
653 |
|
|
|a Photoreceptor Cells / drug effects
|
653 |
|
|
|a Docosahexaenoic Acids / pharmacology
|
653 |
|
|
|a Oxidative stress
|
653 |
|
|
|a Neuroprotective Agents
|
653 |
|
|
|a Neuroprotection
|
653 |
|
|
|a Retinal Pigment Epithelium / physiology
|
653 |
|
|
|a Photoreceptors
|
653 |
|
|
|a Fatty Acids, Omega-3
|
653 |
|
|
|a Receptors, Adiponectin / metabolism
|
653 |
|
|
|a Photoreceptor Cells / metabolism
|
653 |
|
|
|a Neuroprotective agents
|
653 |
|
|
|a Photoreceptor Cells / pathology
|
653 |
|
|
|a Oxidative Stress
|
653 |
|
|
|a Retinal degeneration / Prevention
|
653 |
|
|
|a Macular Degeneration / prevention & control
|
653 |
|
|
|a Fatty Acids, Essential
|
653 |
|
|
|a Docosahexaenoic acid / Health aspects
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b HST
|a Henry Stewart Talks
|
490 |
0 |
|
|a Macular degeneration
|
500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
856 |
4 |
2 |
|u https://hstalks.com/bs/p/979
|3 Series
|
856 |
4 |
0 |
|u https://hstalks.com/bs/4033
|x Verlag
|z Streaming video file
|
082 |
0 |
|
|a 570
|